Related Experiment Video
Updated: Jun 10, 2025
05:51
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
3.6K
Parkinson's Disease Treatment: A Bibliometric Analysis
Billy McBenedict1, Wilhelmina N Hauwanga2, Gustavo Ienaco3
1Neurosurgery, Fluminense Federal University, Niterói, BRA.
Cureus
|October 18, 2024
Summary
This study analyzed Parkinson's disease (PD) research trends, finding increased output from 2000-2018, led by the US. Research has since declined, highlighting the need for continued global collaboration in PD treatment strategies.
Area of Science:
- Neurology
- Neuroscience
- Medical Research
Background:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder with increasing global prevalence.
- Motor and non-motor symptoms significantly impact patient quality of life.
- Effective treatment strategies are crucial due to the rising incidence of PD.
Purpose of the Study:
- To review current Parkinson's disease (PD) treatment modalities.
- To conduct a bibliometric analysis of PD treatment research trends and impact.
- To identify key research areas, influential studies, and collaborative networks in PD treatment.
Main Methods:
- Comprehensive literature search of the Web of Science Core Collection (WoSCC) database.
- Bibliometric analysis using Biblioshiny and VOSviewer.
- Analysis of publication trends, citations, h-index, and country/institutional contributions.
Main Results:
- Significant increase in PD research output from 2000, peaking around 2017-2018, followed by a post-2020 decline.
- United States led research production, followed by China, Canada, and the UK.
- Dopamine replacement therapy and deep brain stimulation (DBS) identified as key treatment trends.
Conclusions:
- Bibliometric analysis revealed trends and impacts in Parkinson's disease (PD) treatment research.
- Leading countries (US, China, Canada, UK) and institutions (University of Toronto, Johns Hopkins, Harvard) significantly contributed.
- International collaborations are vital for advancing PD research and treatment strategies.
Related Concept Videos
01:24Parkinson's Disease: Treatment
231
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
231
01:15Parkinson's Disease: Overview
487
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
487
01:37Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K